Liquidia is a biopharmaceutical company focused on the development and commercialization of products that address unmet patient needs, with current focus directed towards the treatment of pulmonary arterial hypertension (PAH). 

Biotechnology

Education

Liquidia

Liquidia's headquarters in Morrisville, NC, United States

Roger Jeffs

Michael Hunter

Beth Anne Lang

Jason Adair

Sarah Krepp

Jeff Kindig

Derek Schorzman

Scott Moomaw

Rajeev Saggar

Mike Kaseta

Rusty Schundler

Joanna Horobin

David Johnson

Stephen Bloch

Arthur Kirsch

Paul Manning

Katie Rielly-Gauvin

Raman Singh

The Management team at Liquidia is responsible for setting the strategic direction and overseeing the overall operations of the company. This includes driving the development and commercialization of innovative therapies for pulmonary arterial hypertension, ensuring compliance with regulatory standards, and fostering a collaborative corporate culture. By leveraging expertise across various functions, the team aims to achieve organizational goals while addressing critical patient needs in the biopharmaceutical landscape.

Management

The Sales and Marketing team at Liquidia plays a crucial role in driving awareness and adoption of the company's biopharmaceutical products, particularly for pulmonary arterial hypertension. This team is responsible for developing strategic marketing initiatives, managing relationships with healthcare providers, and executing sales strategies to maximize product reach and impact. By collaborating across roles, they ensure that the company effectively addresses unmet patient needs while achieving commercial objectives.

Sales and Marketing

The Research and Development team at Liquidia is responsible for the innovative design and advancement of therapeutic products targeting pulmonary arterial hypertension (PAH). This team conducts cutting-edge research, formulates drug candidates, and ensures quality control throughout the development process, ultimately aiming to address significant patient needs and bring effective solutions to market.

Research and Development

The Leadership Team at Liquidia is responsible for setting the strategic direction of the company, overseeing the development and commercialization of innovative therapies for pulmonary arterial hypertension (PAH), and ensuring operational efficiencies across all departments. This team collaborates on key decisions, financial management, and market strategies to drive growth and address unmet patient needs effectively.

Leadership Team

The Accounting and Financial Operations team at Liquidia is responsible for managing the company's financial reporting, budgeting, and compliance processes. They ensure accurate financial statements, oversee accounting practices, and provide strategic financial insights to support the company's mission in developing innovative treatments for pulmonary arterial hypertension. With a focus on transparency and regulatory adherence, the team plays a critical role in maintaining the financial health of the organization while enabling its growth and innovation.

Accounting and Financial Operations

The Medical Affairs Team at Liquidia is responsible for providing scientific and clinical expertise to support the development and commercialization of biopharmaceutical products for pulmonary arterial hypertension (PAH). This team engages with healthcare professionals, conducts educational initiatives, and ensures that medical information is accurately communicated, fostering collaboration between research and clinical practice to address unmet patient needs.

Liquidia

Org chart

Board & advisors

Teams

Management

Sales and Marketing

Research and Development

Leadership Team

Accounting and Financial Operations

Medical Affairs Team

Offices

Liquidia

Org chart

Board & advisors

Teams

Management

Sales and Marketing

Research and Development

Leadership Team

Accounting and Financial Operations

Medical Affairs Team

Offices

Related companies